Close Menu

NEW YORK (360Dx) – Ortho Clinical Diagnostics has applied for US Food and Drug Administration clearance of an integrated system for mid- and high-volume labs that it anticipates launching in the US early next year.

The high-throughput system combines automated clinical chemistry and immunoassay testing for a broad range of assays with thin film, dry slide technology that speeds throughput for selected assays.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.